Tax

State and Local Income Taxes, Net

Vertex Pharmaceuticals State and Local Income Taxes, Net remained flat by 0.0% to $8.98M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 69.6%, from $29.55M to $8.98M. Over 2 years (FY 2023 to FY 2025), State and Local Income Taxes, Net shows a downward trend with a -11.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionTax
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026

How to read this metric

Higher values indicate increased tax burdens in specific operating regions.

Detailed definition

The net expense incurred for state and local income taxes after accounting for the federal tax deduction benefit. This r...

Peer comparison

Common tax disclosure for companies with significant domestic operations.

Metric ID: cat_state_and_local_income_taxes_net

Historical Data

3 years
 FY'23FY'24FY'25
Value$46.20M$118.20M$35.90M
YoY Change+155.8%-69.6%
Range$35.90M$118.20M
CAGR-11.8%
Avg YoY Growth+43.1%
Median YoY Growth+43.1%

State and Local Income Taxes, Net at Other Companies

Frequently Asked Questions

What is Vertex Pharmaceuticals's state and local income taxes, net?
Vertex Pharmaceuticals (VRTX) reported state and local income taxes, net of $8.98M in Q4 2025.
How has Vertex Pharmaceuticals's state and local income taxes, net changed year-over-year?
Vertex Pharmaceuticals's state and local income taxes, net decreased by 69.6% year-over-year, from $29.55M to $8.98M.
What is the long-term trend for Vertex Pharmaceuticals's state and local income taxes, net?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's state and local income taxes, net has grown at a -11.8% compound annual growth rate (CAGR), from $46.20M to $35.90M.
What does state and local income taxes, net mean?
Net cost of state and local income taxes.